Investigations Into Sepsis-associated Acute Kidney Injury

University Hospital of North Norway

Status: Enrolling

Conditions: Acute Kidney Injury

Treatments: Drug: Para Aminohippurate

Study type: Observational

Funder types: Other

Identifiers

NCT05694624

Record ID 3055

Details and patient eligibility

About

In this study the investigators would like to study systemic and regional disturbances in patients with sepsis-associated acute kidney injury and in healthy controls undergoing laparoscopic abdominal surgery. Specifically study metabolic, hemodynamic and oxygen transport variables.

Full description

Acute kidney injury (AKI) in patients with sepsis has a very poor prognosis with up to 60% mortality. The pathobiology remains to be fully understood. Creatine and phosphocreatine, products of arginine metabolism through L-arginine:glycine amidinotransferase (AGAT) and its sister enzyme guanidinoacetate N-methyl-transferase (GAMT), provide an energy-buffering system that is essential for intracellular adenosine triphosphate (ATP) supply. We hypothesized that sepsis associated AKI may be caused by failure of this energy-buffering system. In series of pilot studies, we explored metabolic and bioenergetic patterns in patients and animals with high risk of developing AKI. These data suggest that sepsis associated AKI may be caused by failure of this alternative renal energy source. In the current application we propose a clinical investigation of renal metabolism and renal bioenergetics in patients with high and low risk of developing sepsis associated AKI. The primary objective is to directly investigate renal AGAT activity through the arginyl metabolites homoarginine, guanidino acetate, and creatine. Secondary objectives are to study renal and systemic hemodynamics, renal oxygenation, glomerular filtration rate (GFR), renal tubular function, and mitochondrial respiration.

Enrollment: 20 estimated patients

Sex: All

Ages: 18 to 100 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria sepsis group:

• Sepsis diagnosed or suspected
• Normal premorbid serum creatinine measured or anticipated (if data are not available)
• Normovolemia as indicated by a pulse pressure variation less than 12%

Comparator group

• Previously healthy individuals scheduled for laparoscopic colon cancer resection

• Normal creatinine levels within 3 months before admittance to hospital.

  • Patients admitted to the intensive care unit with sepsis diagnosed or suspected
  • Previously healthy patients listed for elective colon cancer surgery

Exclusion Criteria:

Trial design

20 participants in 2 patient groups

Sepsis patients

Description:

Patients admitted to the intensive care unit with sepsis diagnosed or suspected

Treatment:

Drug: Para Aminohippurate

Surgical patients

Description:

Previously healthy patients who are operated for colon cancer with laparoscopic technique.

Treatment:

Drug: Para Aminohippurate